Unitree Technology's market value evaporates after IPO amid commercialization doubts

Chinese humanoid robot manufacturer Unitree Technology has experienced a dramatic market value decline, losing 69.8 billion yuan (approximately $9.6 billion) in just three trading days following its debut on the Shanghai STAR Market. The company's initial public offering on August 19th saw its stock surge significantly, reaching 1100 yuan per share at its peak before closing at 845 yuan on its first day, valuing it at 341.77 billion yuan.

However, the momentum quickly reversed. Unitree's stock dropped 18.7% on the second day and fell another 2.1% on August 21st, closing at 672.41 yuan. This sharp decline brought its market capitalization down to 271.97 billion yuan, wiping out nearly 70 billion yuan in investor value within a short period.

Unitree CEO Wang Xingxing acknowledged the current limitations of humanoid robots, stating that their efficiency still falls short of human capabilities and that they are not yet prepared for widespread commercial application. This candid admission highlights the significant gap between the technology's potential and its current market readiness.

Analysts suggest that the initial high valuation was fueled by policy-driven optimism and Unitree's unique position as a publicly traded humanoid robot company. However, concerns about market liquidity following a series of large IPOs and sector rotation pressures have contributed to the stock's pullback. Experts point to the substantial challenges Unitree faces in penetrating manufacturing and service sectors and in demonstrating its growth trajectory.

Further insights from investors indicate a potential bubble in the embodied AI race, with a lack of a truly sustainable commercial cycle. While Unitree's robots are utilized in research, performance, and exhibition settings, their deployment in industrial scenarios like smart manufacturing or inspections remains commercially unproven. Unitree's own disclosures reveal that from January to September 2025, revenue from humanoid robots was predominantly from scientific research and education (73.6%), with commercial and industrial applications making up smaller portions.

“

Humanoid robot efficiency still has a gap compared to real people, and the product is not yet ready for large-scale commercialization.